VBI Vaccinesstock is being impacted by recent insider buying, in which the Chief Medical Officer of the company Diaz-Mitoma Francisco purchases shares. On June 27, …
Tag: NASDAQ:VBIV
VBI Vaccines Inc. (NASDAQ:VBIV) announced positive top-line data from its Phase III PROTECT trial comparing its Sci-B-Vac trivalent hepatitis B vaccine to GlaxoSmithKline’s Engerix-B vaccine. The trial found …
Immunic, Inc. (NASDAQ:IMUX) announced that Hella Kohlhof, Ph.D., Chief Scientific Officer of Immunic, will present today previously unpublished data regarding the company’s lead program, IMU-838, at …